Prognostic Impact of Myosteatosis on Mortality in Hospitalized Patients with COVID-19
Open Access
- 18 September 2022
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 12 (9) , 2255
Abstract
Body composition, including sarcopenia, adipose tissue, and myosteatosis, is associated with unfavorable clinical outcomes in patients with coronavirus disease (COVID-19). However, few studies have identified the impact of body composition, including pre-existing risk factors, on COVID-19 mortality. Therefore, this study aimed to evaluate the effect of body composition, including pre-existing risk factors, on mortality in hospitalized patients with COVID-19. This two-center retrospective study included 127 hospitalized patients with COVID-19 who underwent unenhanced chest computed tomography (CT) between February and April 2020. Using the cross-sectional CT images at the L2 vertebra level, we analyzed the body composition, including skeletal muscle mass, visceral to subcutaneous adipose tissue ratio (VSR), and muscle density using the Hounsfield unit (HU). Of 127 patients with COVID-19, 16 (12.6%) died. Compared with survivors, non-survivors had low muscle density (41.9 vs. 32.2 HU, p < 0.001) and high proportion of myosteatosis (4.5 vs. 62.5%, p < 0.001). Cox regression analyses revealed diabetes (hazard ratio [HR], 3.587), myosteatosis (HR, 3.667), and a high fibrosis-4 index (HR, 1.213) as significant risk factors for mortality in patients with COVID-19. Myosteatosis was associated with mortality in hospitalized patients with COVID-19, independent of pre-existing prognostic factors.Keywords
Funding Information
- 2020 Yeungnam University Research Grant (2021R1G1A1094767)
- Bio & Medical Technology Development Program of the National Research Foundation (NRF) (2021R1G1A1094767)
- Korean government (2021R1G1A1094767)
This publication has 40 references indexed in Scilit:
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in ItalyJAMA, 2020
- Automated body composition analysis of clinically acquired computed tomography scans using neural networksClinical Nutrition, 2020
- Mechanisms Underlying Metabolic Syndrome-Related Sarcopenia and Possible Therapeutic MeasuresInternational Journal of Molecular Sciences, 2019
- Recent Issues on Body Composition Imaging for Sarcopenia EvaluationKorean Journal of Radiology, 2019
- The deterioration of muscle mass and radiodensity is prognostic of poor survival in stage I–III colorectal cancer: a population‐based cohort study (C‐SCANS)Journal of Cachexia, Sarcopenia and Muscle, 2018
- A multicenter study to define sarcopenia in patients with end‐stage liver diseaseLiver Transplantation, 2017
- Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinomaJournal of Hepatology, 2015
- A New Body Shape Index Predicts Mortality Hazard Independently of Body Mass IndexPLOS ONE, 2012
- Does Measurement Site for Visceral and Abdominal Subcutaneous Adipose Tissue Alter Associations With the Metabolic Syndrome?Diabetes Care, 2006